CAR T cells based on fully human T cell receptor-mimetic antibodies exhibit potent antitumor activity in vivo.
Salzler R, DiLillo DJ, Saotome K, Bray K, Mohrs K, Hwang H, Cygan KJ, Shah D, Rye-Weller A, Kundu K, Badithe A, Zhang X, Garnova E, Torres M, Dhanik A, Babb R, Delfino FJ, Thwaites C, Dudgeon D, Moore MJ, Meagher TC, Decker CE, Owczarek T, Gleason JA, Yang X, Suh D, Lee WY, Welsh R, MacDonald D, Hansen J, Guo C, Kirshner JR, Thurston G, Huang T, Franklin MC, Yancopoulos GD, Lin JC, Macdonald LE, Murphy AJ, Chen G, Olsen O, Olson WC.
Salzler R, et al. Among authors: delfino fj.
Sci Transl Med. 2025 Mar 26;17(791):eado9371. doi: 10.1126/scitranslmed.ado9371. Epub 2025 Mar 26.
Sci Transl Med. 2025.
PMID: 40138458